168899-47-6 Usage
Uses
Used in Pharmaceutical Industry:
Benzoic acid, 3,4-dihydroxy-2-methylis used as a pharmaceutical ingredient for its anticoagulant and antithrombotic properties, which are beneficial in the prevention and treatment of blood clots and related conditions.
Used in Nutraceutical Industry:
In the nutraceutical sector, Benzoic acid, 3,4-dihydroxy-2-methylis utilized for its antioxidant and anti-inflammatory effects, contributing to the development of health supplements and functional foods that promote overall wellness and reduce inflammation.
Used in Cardiovascular Health Applications:
Benzoic acid, 3,4-dihydroxy-2-methylis studied for its potential role in reducing blood pressure and protecting against cardiovascular diseases, making it a candidate for use in heart health supplements and related medicinal formulations.
Used in Traditional Chinese Medicine:
Benzoic acid, 3,4-dihydroxy-2-Methylhas been a part of traditional Chinese medicine, where it is used for its various health benefits, including its anticoagulant and antithrombotic properties, which are particularly important in the treatment of blood-related disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 168899-47-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,8,8,9 and 9 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 168899-47:
(8*1)+(7*6)+(6*8)+(5*8)+(4*9)+(3*9)+(2*4)+(1*7)=216
216 % 10 = 6
So 168899-47-6 is a valid CAS Registry Number.
168899-47-6Relevant articles and documents
Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
-
Page/Page column 33, (2010/02/14)
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand
HIV protease inhibitors
-
, (2008/06/13)
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
HIV protease inhibitors
-
, (2008/06/13)
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.